Acadia Pharmaceuticals | ACAD - Pasivo Circulante

Precio De Mercado
21.96
Cambio Diario
-0.15 -0.68%
Mensual
-0.23%
Anual
49.08%
Q2 Expectativa
21.49




Pasivo Circulante Cambio Fecha
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
ALKERMES USD 543.44M 69.08M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Biogen USD 3.35B 59.4M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Cara Therapeutics USD 11.04M 362K 2025-09
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Cytokinetics USD 202.45M 60.31M 2025-12
Eisai JPY 387.67B 9.42B 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Incyte USD 1.52B 176.44M 2025-12
J&J USD 57.72B 3.59B 2026-03
Moderna USD 1.99B 306M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Prothena USD 40.84M 10.59M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12